Since publishing its financial results for 2024 at the end of January, the share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has struggled to recover as about $6 billion has been wiped off its market cap,…
Since publishing its financial results for 2024 at the end of January, the share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has struggled to recover as about $6 billion has been wiped off its market cap,…